Seer (SEER) Asset Writedowns and Impairment (2022 - 2026)
Seer (SEER) posted quarterly Asset Writedowns and Impairment of -$10000.0 for Q1 2026, down 130.3% year-over-year from $33000.0 in Q1 2025, and down 116.39% quarter-over-quarter from $61000.0 in Q4 2025.
Seer (SEER) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
Seer's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 130.3% year-over-year to -$10000.0; the TTM figure through Mar 2026 stood at $105000.0 (down 48.53% YoY), while the FY2025 annual figure was $148000.0, down 17.32% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$10000.0, down from $61000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $525000.0 in Q3 2023, with the low at -$10000.0 in Q1 2026.
- The 5-year median for Asset Writedowns and Impairment is $54000.0 (2024), against an average of $130461.5.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment surged 312.5% in 2025, then plunged 130.3% in 2026.
- Seer's Asset Writedowns and Impairment stood at $507000.0 in 2022, then slumped by 90.73% to $47000.0 in 2023, then climbed by 10.64% to $52000.0 in 2024, then rose by 17.31% to $61000.0 in 2025, then sank by 116.39% to -$10000.0 in 2026.
- Business Quant data shows SEER's Asset Writedowns and Impairment at -$10000.0 in Q1 2026, $61000.0 in Q4 2025, and $54000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Dec 31, 2023 | 47,000.00 |